HIRA to evaluate economic effectiveness of antihypertensive drugs next year
Published: 2008-11-13 06:58:00
Updated: 2008-11-13 06:58:00
The Health Insurance Review and Assessment Service (HIRA) plans to evaluate the economic effectiveness of antihypertensive agents and other medicines between 2009 and 2013 and gradually readjust prices and exclude items that are the least cost-effective.
In a recent international symposium, HI...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
